Allergic Rhinitis Epidemiology Forecast Report 2021-2030: Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan - ResearchAndMarkets.com

The "Allergic Rhinitis - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

This 'Allergic Rhinitis - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Allergic Rhinitis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

The Allergic Rhinitis epidemiology division provides insights about historical and current Allergic Rhinitis patient pool and forecasted trends for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of The report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

In the year 2020, the total prevalent cases of Allergic Rhinitis was 188.40 million cases in the 7MM which are expected to grow during the study period, i.e., 2018-2030.

The disease epidemiology covered in the report provides historical as well as forecasted Allergic Rhinitis epidemiology [segmented as Total Prevalent Cases of Allergic Rhinitis, Total Diagnosed Cases of Allergic Rhinitis, Total Age group-specific Cases of Allergic Rhinitis, Total Allergen-specific Cases of Allergic Rhinitis, and Total Treated Cases of Allergic Rhinitis] in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2018 to 2030.

Country Wise-Allergic Rhinitis Epidemiology

Estimates show that the highest cases of Allergic Rhinitis in the 7MM were in Japan, followed by the United States, Germany, France, the United Kingdom, Italy, and Spain in 2020.

• In the United States, the total number of prevalent cases of Allergic Rhinitis was 52.26 million cases in the year 2020 which are expected to grow during the study period, i.e., 2018-2030.
• In the year 2020, the total prevalent cases of Allergic Rhinitis were 76.86 million cases in EU-5 which are expected to grow during the study period, i.e., 2018-2030.
• In Japan, the total number of prevalent cases of Allergic Rhinitis was 59.29 million cases in the year 2020 which are expected to grow during the study period, i.e., 2018-2030.

Study Period: 2018-2030

• In the year 2020, the total prevalent case of Allergic Rhinitis was 188.40 million cases in the 7MM, and the US, in 2020, accounted for 52.26 million cases (the second highest number), which will probably rise during the study period, i.e., 2018-2030.
• In the 7MM, the total diagnosed cases of Allergic Rhinitis was 97.69 million cases, which will probably rise during the study period, i.e., 2018-2030. In the 7MM, the highest number of diagnosed cases of Allergic Rhinitis were observed in the US.
• In the 7MM, the total age group -specific cases of Allergic Rhinitis were 9.65 million, 22.52 million and 156.23 million cases for the age groups < 10 years, 10 to 17 years, and ?18 years, respectively in 2020.
• In the 7MM, the total allergen -specific cases of Allergic Rhinitis were 19.09 million, 23.49 million, 30.58 million, 6.55 million, 8.80 million, and 4.65 million cases for grass pollen, mites, tree pollen, herbaceous pollen, animal dander, and fungal spores, respectively in 2020.

Report Highlights

• 10-Year Forecast of Allergic Rhinitis epidemiology
• 7MM Coverage
• Total Prevalent Cases of Allergic Rhinitis
• Total Diagnosed Cases of Allergic Rhinitis
• Total Age group-Specific Cases of Allergic Rhinitis
• Total Allergen-Specific Cases of Allergic Rhinitis
• Total Treated Cases of Allergic Rhinitis

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Key Topics Covered:

1. Key Insights

2. Report Introduction

3. Executive Summary of Allergic rhinitis

3.1. Key Events

4. Epidemiology Methodology

5. Disease Background and Overview

5.1. Introduction

5.2. Types of Allergic Rhinitis

5.3. Signs and Symptoms of Allergic Rhinitis

5.4. Risk Factors and Causes of Allergic rhinitis

5.5. Pathogenesis of Allergic rhinitis

5.6. Genetics of Allergic rhinitis

5.7. Complications of Allergic rhinitis

6. Diagnosis of Allergic rhinitis

6.1. Diagnostic Algorithm of Allergic rhinitis

6.2. Detailed History from the patient

6.3. Skin Test

6.4. IgE Antibody Test

6.5. Nasal Allergen Challenges (NAC)

6.6. Differential Diagnosis of Allergic Rhinitis

6.7. Diagnosis Guidelines of Allergic Rhinitis

6.7.1. American Academy of Otolaryngology-Head and Neck Surgery (2015)

6.7.2. Rhinitis 2020: A Practice Parameter

7. Conclusion

8. Epidemiology and Patient Population

8.1. Key Findings

8.2. Epidemiology of Allergic Rhinitis

8.3. Epidemiology Scenario

8.3.1. Total Prevalent Cases of Allergic Rhinitis

8.3.2. Total Diagnosed Cases of Allergic Rhinitis

8.3.3. Total Age group-specific Cases of Allergic Rhinitis

8.3.4. Total Allergen-specific Cases of Allergic Rhinitis

8.3.5. Total Treated Cases of Allergic Rhinitis

9. KOL Views

10. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/enmt8s

View source version on businesswire.com: https://www.businesswire.com/news/home/20220117005244/en/